Lei Y, Tang Z, He L, Yin M, Qi J, Guo B, Zhao S, Z. Susceptibility of seasonal influenza viruses to neuraminidase inhibitors and baloxavir in Qinghai Province, 2021-2025. Infect Med (Beijing). 2026 Oct 9;5(4):100288
Background: This study aimed to analyze whether seasonal influenza viruses circulating in Qinghai Province from 2021 to 2025 are susceptible to neuraminidase inhibitors (oseltamivir and zanamivir) and baloxavir.
Methods: Based on routine surveillance, 214 isolates were randomly selected for phenotypic neuraminidase inhibition testing against oseltamivir and zanamivir. The half-maximal inhibitory concentration was calculated and compared with subtype/lineage-specific median reference values. Neuraminidase genes of isolates showing reduced inhibition (RI) or highly reduced inhibition (HRI) were sequenced. Additionally, polymerase acidic gene sequencing used 141 randomly selected isolates to screen for known baloxavir resistance-associated substitutions.
Results: In total, 212 (99.07%) isolates were sensitive to oseltamivir; two B/Victoria (0.93%) showed RI. For zanamivir, 209 (97.66%) were sensitive; 4 (1.87%) showed RI (1 A[H1N1]pdm09, 3 B/Victoria), while 1 (0.47%) A(H1N1)pdm09 showed HRI. Among the seven isolates with abnormal neuraminidase inhibition testing results, only one B/Victoria (RI to zanamivir) carried a well-known resistance mutation (D197N). One A(H1N1)pdm09 (HRI to zanamivir) carried K331R, and one B/Victoria (RI to oseltamivir) carried Y214H. However, evidence for these two substitutions conferring resistance remains insufficient, requiring functional validation. The four remaining isolates had no amino acid changes in neuraminidase compared with the consensus sequences of contemporaneous sensitive isolates. Furthermore, no isolates harbored any known baloxavir resistance-associated mutations in the polymerase acidic gene.
Conclusion: Seasonal influenza viruses circulating in Qinghai in 2021-2025 remained largely susceptible to neuraminidase inhibitors, without known baloxavir resistance-associated substitutions detected by genotypic screening. Thus, continuous surveillance integrating phenotypic and genotypic methods is essential.
Methods: Based on routine surveillance, 214 isolates were randomly selected for phenotypic neuraminidase inhibition testing against oseltamivir and zanamivir. The half-maximal inhibitory concentration was calculated and compared with subtype/lineage-specific median reference values. Neuraminidase genes of isolates showing reduced inhibition (RI) or highly reduced inhibition (HRI) were sequenced. Additionally, polymerase acidic gene sequencing used 141 randomly selected isolates to screen for known baloxavir resistance-associated substitutions.
Results: In total, 212 (99.07%) isolates were sensitive to oseltamivir; two B/Victoria (0.93%) showed RI. For zanamivir, 209 (97.66%) were sensitive; 4 (1.87%) showed RI (1 A[H1N1]pdm09, 3 B/Victoria), while 1 (0.47%) A(H1N1)pdm09 showed HRI. Among the seven isolates with abnormal neuraminidase inhibition testing results, only one B/Victoria (RI to zanamivir) carried a well-known resistance mutation (D197N). One A(H1N1)pdm09 (HRI to zanamivir) carried K331R, and one B/Victoria (RI to oseltamivir) carried Y214H. However, evidence for these two substitutions conferring resistance remains insufficient, requiring functional validation. The four remaining isolates had no amino acid changes in neuraminidase compared with the consensus sequences of contemporaneous sensitive isolates. Furthermore, no isolates harbored any known baloxavir resistance-associated mutations in the polymerase acidic gene.
Conclusion: Seasonal influenza viruses circulating in Qinghai in 2021-2025 remained largely susceptible to neuraminidase inhibitors, without known baloxavir resistance-associated substitutions detected by genotypic screening. Thus, continuous surveillance integrating phenotypic and genotypic methods is essential.
See Also:
Latest articles in those days:
- Weekly US Influenza Surveillance Report: Key Updates for Week 45, ending November 14, 2026 11 hours ago
- Anatomical Compartmentalization in Chickens Drives Divergent H9N2 Influenza Evolution Toward Human Receptor Binding and Immune Escape 1 days ago
- Epidemiologic Variability and Clinical Severity Across 11 Influenza Seasons in Children 2 days ago
- Molecular Epidemiology of Clade 2.3.4.4b H5N1 High-Pathogenicity Avian Influenza in South Africa, 2025-2026 2 days ago
- Structural basis of avian-to-human receptor-binding adaptation in H9Ny influenza A virus hemagglutinin 2 days ago
[Go Top] [Close Window]


